INSM Stock Analysis: Buy, Sell, or Hold?
INSM - Insmed, Inc.
$156.87
-0.95 (-0.60%)
▼
5d:
+0.42%
30d:
-9.89%
90d:
-6.04%
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 19, 2026
16d
Get Alerted When INSM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INSM shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: INSM shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: INSM is currently trading at $156.87, which is considered oversold relative to its 30-day fair value range of $159.58 to $175.70.
Technical Outlook: Technically, INSM is in a uptrend. The price is currently testing key support at $153.09. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $215.10 (+37.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INSM is in a uptrend. The price is currently testing key support at $153.09. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $215.10 (+37.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$159.58 -
$175.70
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.1% below Wall St target ($215.10)
Fair Price Analysis
30-Day Fair Range
$159.58 -
$175.70
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$153.09
Resistance Level
$165.47
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-59.34
Wall Street Target
$215.10
(+37.1%)
Revenue Growth (YoY)
52.4%
Profit Margin
-264.8%
Last updated: February 02, 2026 2:40 AM ET
Data refreshes hourly during market hours. Next update: 3:40 AM
Data refreshes hourly during market hours. Next update: 3:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INSM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr.
SELL
2025-09-22
Melvin Md Sharoky
SELL
10000 shares
2025-09-12
Orlov S Nicole Schaeffer
SELL
76520 shares
2025-09-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 59 HOLD |
Advanced INSM Option Strategies
Professional options setups generated by AI based on today's INSM price and gamma walls.
